Table 2 Descriptive table of 676 ER-negative breast cancer cases by Scottish index for multiple deprivation (SIMD) diagnosed in Scotland from 2007–2008

Event type

Dead, no recurrence

105

(15.5%)

24

(13.3%)

28

(16.3%)

21

(14.5%)

23

(20.2%)

9

(14.1%)

Alive, no recurrence

386

(57.1%)

118

(65.2%)

98

(57.0%)

73

(50.3%)

64

(56.1%)

33

(51.6%)

Recurrence (+/− death following recurrence)

185

(27.4%)

39

(21.5%)

46

(26.7%)

51

(35.2%)

27

(23.7%)

22

(34.4%)

Cause of death^a

Breast cancer

116

(46.8%)

24

(44.4%)

27

(43.5%)

34

(55.7%)

18

(40.9%)

14

(48.1%)

Non breast cancer death

61

(24.6%)

14

(25.9%)

15

(24.2%)

10

(16.4%)

16

(36.4%)

6

(22.2%)

Tumour grade

Grade 1/2

105

(16.1%)

32

(18.6%)

22

(13.4%)

20

(14.3%)

23

(20.4%)

8

(12.5%)

Grade 3

548

(83.9%)

140

(81.4%)

142

(86.6%)

120

(85.7%)

90

(79.6%)

56

(87.5%)

TNM stage

I

131

(32.7%)

34

(34.7%)

33

(33.0%)

21

(23.6%)

23

(32.4%)

20

(46.5%)

II/III

270

(67.3%)

64

(65.3%)

67

(67.0%)

68

(76.4%)

48

(67.6%)

23

(53.5%)

Age at diagnosis

< 50

186

(27.5%)

46

(25.4%)

46

(26.7%)

44

(30.3%)

32

(28.1%)

18

(28.1%)

50–70

348

(51.5%)

100

(55.2%)

91

(52.9%)

71

(49.0%)

54

(47.4%)

32

(50.0%)

70 + 

142

(21.0%)

35

(19.3%)

35

(20.3%)

30

(20.7%)

28

(24.6%)

14

(21.9%)

Treatment received

Breast-conserving surgery

335

(49.6%)

91

(50.3%)

83

(48.3%)

69

(47.6%)

54

(47.4%)

38

(59.4%)

Mastectomy

341

(50.4%)

90

(49.7%)

89

(51.7%)

76

(52.4%)

60

(52.6%)

26

(40.6%)

Chemotherapy

513

(76.0%)

137

(75.7%)

132

(77.2%)

108

(74.5%)

86

(75.4%)

50

(78.1%)

Radiotherapy

492

(73.2%)

134

(74.4%)

126

(73.7%)

103

(71.0%)

82

(73.2%)

47

(73.4%)

Screening^b

Screen detected

114

(32.8%)

28

(28.0%)

26

(28.6%)

26

(36.6%)

19

(35.2%)

15

(46.9%)

Not screen detected

234

(67.2%)

72

(72.0%)

65

(71.4%)

45

(63.4%)

35

(64.8%)

17

(53.1%)